TY - JOUR
T1 - Risk of colistin resistance on the rise
AU - Callens, B.
AU - Haesebrouck, F.
AU - Dewulf, J.
AU - Boyen, F.
AU - Butaye, P.
AU - Catry, B.
AU - Wattiau, P.
AU - De Graef, E.
N1 - Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].
PY - 2016
Y1 - 2016
N2 - In a recent article from China, a transferable resistance mechanism has been described in Escherichia coli (E. coli), isolated from food-producing animals, meat and hospital patients (Liu et al., 2015). Recently, this resistance mechanism has also been found in Denmark, France, the United Kingdom and Belgium. Colistin is considered as one of the last resort treatments against multi-resistant bacteria in human medicine, especially for patients with cystic fibrosis. Alertness is needed and the new resistance mechanism has to be detected properly in animal and human related bacteria.
AB - In a recent article from China, a transferable resistance mechanism has been described in Escherichia coli (E. coli), isolated from food-producing animals, meat and hospital patients (Liu et al., 2015). Recently, this resistance mechanism has also been found in Denmark, France, the United Kingdom and Belgium. Colistin is considered as one of the last resort treatments against multi-resistant bacteria in human medicine, especially for patients with cystic fibrosis. Alertness is needed and the new resistance mechanism has to be detected properly in animal and human related bacteria.
UR - http://www.scopus.com/inward/record.url?scp=84961239205&partnerID=8YFLogxK
UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-84961239205&origin=recordpage
M3 - RGC 21 - Publication in refereed journal
SN - 0303-9021
VL - 85
SP - 36
EP - 40
JO - Vlaams Diergeneeskundig Tijdschrift
JF - Vlaams Diergeneeskundig Tijdschrift
IS - 1
ER -
